Found: 80
Select item for more details and to access through your institution.
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 7, p. 4599, doi. 10.1007/s00415-024-12417-x
- By:
- Publication type:
- Article
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 5, p. 490, doi. 10.1001/jamaneurol.2024.0395
- By:
- Publication type:
- Article
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?
- Published in:
- Drugs, 2023, v. 83, n. 15, p. 1351, doi. 10.1007/s40265-023-01942-0
- By:
- Publication type:
- Article
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 719, doi. 10.1177/13524585231161494
- By:
- Publication type:
- Article
Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 1, p. 413, doi. 10.1007/s00415-022-11341-2
- By:
- Publication type:
- Article
Multiple sclerosis clinical decision support system based on projection to reference datasets.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 12, p. 1863, doi. 10.1002/acn3.51649
- By:
- Publication type:
- Article
COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 10, p. 5571, doi. 10.1007/s00415-022-11215-7
- By:
- Publication type:
- Article
Disability progression in multiple sclerosis patients using early first‐line treatments.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 9, p. 2761, doi. 10.1111/ene.15422
- By:
- Publication type:
- Article
Body mass index as a predictor of MS activity and progression among participants in BENEFIT.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1277, doi. 10.1177/13524585211061861
- By:
- Publication type:
- Article
Determinants of therapeutic lag in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 12, p. 1838, doi. 10.1177/1352458520981300
- By:
- Publication type:
- Article
Cumulative effects of therapies on disability in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1760, doi. 10.1177/1352458520980366
- By:
- Publication type:
- Article
1298Associations of DMT therapies with COVID-19 severity in multiple sclerosis.
- Published in:
- International Journal of Epidemiology, 2021, v. 50, p. 1, doi. 10.1093/ije/dyab168.604
- By:
- Publication type:
- Article
Untreated patients with multiple sclerosis: A study of French expert centers.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 6, p. 2026, doi. 10.1111/ene.14790
- By:
- Publication type:
- Article
Mass Cytometry Identifies Expansion of T-bet<sup>+</sup> B Cells and CD206<sup>+</sup> Monocytes in Early Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.653577
- By:
- Publication type:
- Article
Comparison of Simoa<sup>TM</sup> and Ella<sup>TM</sup> to assess serum neurofilament‐light chain in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 5, p. 1141, doi. 10.1002/acn3.51355
- By:
- Publication type:
- Article
Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: The MusiCare questionnaire.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 3, p. 910, doi. 10.1111/ene.14685
- By:
- Publication type:
- Article
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 479, doi. 10.1177/1352458520930620
- By:
- Publication type:
- Article
Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 90, doi. 10.1177/1352458519895450
- By:
- Publication type:
- Article
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1898, doi. 10.1177/1352458519894713
- By:
- Publication type:
- Article
Long‐term effect of first‐line injectable multiple sclerosis treatments: Input of a time‐dependent propensity score.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 12, p. 1680, doi. 10.1002/pds.5154
- By:
- Publication type:
- Article
COVID-19 in people with multiple sclerosis: A global data sharing initiative.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 10, p. 1157, doi. 10.1177/1352458520941485
- By:
- Publication type:
- Article
Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1031, doi. 10.1177/1352458520925369
- By:
- Publication type:
- Article
Aggressive multiple sclerosis (2): Treatment.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1045, doi. 10.1177/1352458520924595
- By:
- Publication type:
- Article
Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 924, doi. 10.1177/1352458519848090
- By:
- Publication type:
- Article
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
(DXT42) Rationale and Design of CLASSIC-MS Study Evaluating Long-Term Efficacy for Patients with Multiple Sclerosis Treated with Cladribine Tablets.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 30
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 1, p. 94, doi. 10.1001/jamaneurol.2019.2670
- By:
- Publication type:
- Article
MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Joint assessment of brain and spinal cord motor tract damage in patients with early RRMS: predominant impact of spinal cord lesions on motor function.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 9, p. 2294, doi. 10.1007/s00415-019-09419-5
- By:
- Publication type:
- Article
Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: A multicentre magnetisation transfer ratio study.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 8, p. 1113, doi. 10.1177/1352458518781999
- By:
- Publication type:
- Article
Measurement of magnetization transfer ratio (MTR) from cervical spinal cord: Multicenter reproducibility and variability.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multiple sclerosis: effect of beta interferon treatment on survival.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 565, doi. 10.1177/1352458518763089
- By:
- Publication type:
- Article
Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Where there is inflammation, treatment may reduce disability progression – No.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 14, p. 1810, doi. 10.1177/1352458518795417
- By:
- Publication type:
- Article
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-up.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 14, p. 1852, doi. 10.1177/1352458517736148
- By:
- Publication type:
- Article
Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers.
- Published in:
- International Journal of Health Geographics, 2017, v. 16, p. 1, doi. 10.1186/s12942-017-0108-6
- By:
- Publication type:
- Article
Sodium intake and multiple sclerosis activity and progression in BENEFIT.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Oral rather than intravenous corticosteroids should be used to treat MS relapses – Yes.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 8, p. 1056, doi. 10.1177/1352458517695893
- By:
- Publication type:
- Article
An excessive risk of suicide may no longer be a reality for multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 6, p. 864, doi. 10.1177/1352458517699873
- By:
- Publication type:
- Article
Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0167556
- By:
- Publication type:
- Article
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 13, p. 1719, doi. 10.1177/1352458516667568
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in a patient with silicosis.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 8, p. 1032, doi. 10.1177/1352458515607649
- By:
- Publication type:
- Article
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 6, p. 817, doi. 10.1177/1352458515601902
- By:
- Publication type:
- Article
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132033
- By:
- Publication type:
- Article
Spinal cord hemorrhage in a patient with neurosarcoidosis on long-term corticosteroid therapy: case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Richard E Gonsette (1929–2014).
- Published in:
- 2015
- By:
- Publication type:
- Obituary
Criteria improving multiple sclerosis diagnosis at the first MRI.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 4, p. 979, doi. 10.1007/s00415-015-7668-9
- By:
- Publication type:
- Article
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 4, p. 1024, doi. 10.1007/s00415-015-7653-3
- By:
- Publication type:
- Article